Načítá se...
Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy
Statins are the first-line choice in Lipid-lowering therapy to reduce cardiovascular risk. In a continuous attempt to optimise treatment success, there is a need for additional research on genes and related molecular pathways that can determine the efficacy and toxicity of lipid-lowering drugs. Seve...
Uloženo v:
| Vydáno v: | Ann Med |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7877934/ https://ncbi.nlm.nih.gov/pubmed/32735150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07853890.2020.1800074 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|